North America
Kyowa Kirin Integrates North America Businesses in Support of Company's 2030 Vision and Rapid Growth Trajectory
New Organizational Structure and Senior Leadership Hires Seek to Strengthen Regional Business Operations, Optimize Investments and Aid in Delivery of First-in-Class Medicines
BEDMINSTER, N.J., March 31, 2021 /PRNewswire/ -- Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, today announced a key milestone in its North American Business Integration (NABI) initiative; specifically, the merger of its Kyowa Kirin Research and Kyowa Kirin Development companies into Kyowa Kirin, Inc. The outcome of this merger is a simpler business structure for the organization and a common set of processes and systems to enhance the productivity and collaborations across North America discovery, development and commercial functions. This new structure will enable the region's continued rapid growth and contributions toward the global organization's New 2030 Vision,
31 March 2021
